Benzinga | Sep 9, 2021 09:27AM EDT

Trinity Biotech Q2 EPS $0.20 Beats $0.07 Estimate, Sales $25.84M Beat $25.00M Estimate

Trinity Biotech (NASDAQ:TRIB) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.07 by 185.71 percent. This is a 1900 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $25.84 million which beat the analyst consensus estimate of $25.00 million by 3.37 percent. This is a 61.28 percent increase over sales of $16.02 million the same period last year.